farnesol has been researched along with Anasarca in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Qamar, W; Sultana, S | 1 |
Ali, F; Khan, AQ; Khan, R; Lateef, A; Qamar, W; Rehman, MU; Sultana, S; Tahir, M | 1 |
Knapp, DR; Langman, MJ; Wakley, EJ | 1 |
1 trial(s) available for farnesol and Anasarca
Article | Year |
---|---|
Treatment of chronic gastric ulcer with carbenoxolone and gefarnate: a comparative trial.
Topics: Body Weight; Chronic Disease; Clinical Trials as Topic; Diuretics; Edema; Farnesol; Fatty Acids; Female; Glycyrrhiza; Humans; Hypertension; Male; Plants, Medicinal; Potassium; Sodium; Stomach Ulcer; Terpenes | 1973 |
2 other study(ies) available for farnesol and Anasarca
Article | Year |
---|---|
Farnesol ameliorates massive inflammation, oxidative stress and lung injury induced by intratracheal instillation of cigarette smoke extract in rats: an initial step in lung chemoprevention.
Topics: Administration, Oral; Animals; Antioxidants; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Edema; Farnesol; Hydrogen Peroxide; Inflammation; Lipid Peroxidation; Lung Injury; Lung Neoplasms; Male; Membrane Lipids; Nicotiana; Oxidative Stress; Phospholipids; Rats; Rats, Wistar; Smoke | 2008 |
Benzo(a)pyrene-induced pulmonary inflammation, edema, surfactant dysfunction, and injuries in rats: alleviation by farnesol.
Topics: Alkaline Phosphatase; Animals; Benzo(a)pyrene; Bronchoalveolar Lavage Fluid; Edema; Epithelial Cells; Epoxide Hydrolases; Farnesol; Glutathione Transferase; L-Lactate Dehydrogenase; Lung; Lung Injury; Male; NADPH-Ferrihemoprotein Reductase; Nitric Oxide; Oxidative Stress; Phospholipids; Pneumonia; Pulmonary Surfactants; Rats; Rats, Wistar | 2012 |